Ceftibuten is a third generation cephalosporine with beta laktamase resistent properties. The drug is a broad-spectrum, oral and allows a single daily dosage which ensures patient compliance. The properties of ceftibuten is compared to ciprofloxacin for the treatment of bronchitis and pneumonia using a clinical trial with a comparative, paralel group, randomized methode. Ceftibuten was given 40…
A retrospective study was conducted to investigate a metastical view of lung tumor patients at the Department of Pulmonology, Faculty of Medicine University of Indonesia/Persahabatan Hospital, Jakarta. Subjects were the patients whom hospitalized from 1984 till 1988 and in 1991. They were 70 cases, consisted of 44 females (61.1 percent) and 26 males (37 percent). The youngest was 14 years old a…
Clarithromycin is a new macrolide antibiotic which is active against Gram-positive and Gram negative bacteria. Community acquired pneumonia is mostly caused by Gram-positive bacilli. The effectiveness of twice daily 250 mg clarithomycin in the treatment of hospitalized patients with community acquired pneumonia was studied. This study is an open clinical trial without control. Subjects were 30 …